Blood Sugar Control After Stomach Cancer Surgery Varies Sharply by Intestinal Reconstruction Method
For patients navigating both stomach cancer and type 2 diabetes, the surgical method used to reconnect the digestive tract after partial stomach...
Search results for "clinical trial"
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.6% in Phase 3 clinical trials, though it did...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition
A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Numb Calves Led Her to Seek Treatment—But the Culprit Wasn’t Her Knee; It Was Her Lower Back
[Summary] Lumbar spinal stenosis can cause numbness and pain to show up first in the legs or calves rather than the...
New AI Model Estimates Children's Blood Carbon Dioxide, Potentially Reducing Painful Needle Sticks
While a child is under general anesthesia, clinicians continuously monitor their breathing status to ensure safe...
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market
The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
Beyond Animal Collagen: Plant-Derived Peptides Emerge as a Clean, Bioactive Alternative
When discussing youthful skin, collagen is almost always part of the conversation. Acting as the body’s internal...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68
Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...